25 XP   0   0   10

Immuneering Corp
Buy, Hold or Sell?

Let's analyze Immuneering together

I guess you are interested in Immuneering Corp. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Immuneering Corp. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Immuneering Corp

I send you an email if I find something interesting about Immuneering Corp.

Quick analysis of Immuneering (30 sec.)










What can you expect buying and holding a share of Immuneering? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$2.65
Expected worth in 1 year
$2.01
How sure are you?
17.6%

+ What do you gain per year?

Total Gains per Share
$-0.64
Return On Investment
-56.9%

For what price can you sell your share?

Current Price per Share
$1.13
Expected price per share
$0 - $1.9
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

1. Valuation of Immuneering (5 min.)




Live pricePrice per Share (EOD)

$1.13

Intrinsic Value Per Share

$-26.09 - $-30.77

Total Value Per Share

$-23.43 - $-28.12

2. Growth of Immuneering (5 min.)




Is Immuneering growing?

Current yearPrevious yearGrowGrow %
How rich?$78.7m$115.7m-$18.6m-19.2%

How much money is Immuneering making?

Current yearPrevious yearGrowGrow %
Making money-$13.5m$256.3m-$269.8m-1,992.7%
Net Profit Margin0.8%-696,772.0%--

How much money comes from the company's main activities?

3. Financial Health of Immuneering (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#391 / 966

Most Revenue
#927 / 966

Most Profit
#619 / 966

Most Efficient
#149 / 966
3rd party ad coffee SUPPORTERis ad-free.

What can you expect buying and holding a share of Immuneering? (5 min.)

Welcome investor! Immuneering's management wants to use your money to grow the business. In return you get a share of Immuneering.

What can you expect buying and holding a share of Immuneering?

First you should know what it really means to hold a share of Immuneering. And how you can make/lose money.

Speculation

The Price per Share of Immuneering is $1.13. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Immuneering.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Immuneering, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $2.65. Based on the TTM, the Book Value Change Per Share is $-0.16 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.39 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Immuneering.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.48-42.7%-0.46-40.4%-0.43-38.2%-0.33-29.6%-0.33-29.6%
Usd Book Value Change Per Share-0.40-35.4%-0.16-14.2%-0.39-34.5%0.1613.8%0.1613.8%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.40-35.4%-0.16-14.2%-0.39-34.5%0.1613.8%0.1613.8%
Usd Price Per Share2.89-7.02-8.57-6.56-6.56-
Price to Earnings Ratio-1.50--3.95--4.94--4.32--4.32-
Price-to-Total Gains Ratio-7.23--6.66--21.86--30.30--30.30-
Price to Book Ratio1.09-2.07-2.23-1.57-1.57-
Price-to-Total Gains Ratio-7.23--6.66--21.86--30.30--30.30-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.13
Number of shares884
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.160.16
Usd Total Gains Per Share-0.160.16
Gains per Quarter (884 shares)-142.10138.05
Gains per Year (884 shares)-568.40552.19
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-568-5780552542
20-1137-1146011041094
30-1705-1714016571646
40-2274-2282022092198
50-2842-2850027612750
60-3410-3418033133302
70-3979-3986038653854
80-4547-4554044184406
90-5116-5122049704958
100-5684-5690055225510

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.017.00.00.0%0.017.00.00.0%0.017.00.00.0%
Book Value Change Per Share1.03.00.025.0%2.010.00.016.7%3.011.03.017.6%3.011.03.017.6%3.011.03.017.6%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.017.00.0%0.00.017.00.0%0.00.017.00.0%
Total Gains per Share1.03.00.025.0%2.010.00.016.7%3.011.03.017.6%3.011.03.017.6%3.011.03.017.6%
3rd party ad coffee SUPPORTERis ad-free.

Fundamentals of Immuneering

About Immuneering Corp

Immuneering Corporation, a clinical-stage oncology company, engages in the development of medicines for broad populations of cancer patients. Its lead product candidates include IMM-1-104, a dual-MEK inhibitor currently under Phase 1/2a clinical trial to treat patients with cancer, including pancreatic, melanoma, colorectal, and non-small cell lung cancer caused by mutations of RAS and/or RAF; and IMM-6-415 is in Investigational New Drug application to treat solid tumors. Immuneering Corporation was incorporated in 2008 and is based in Cambridge, Massachusetts.

Fundamental data was last updated by Penke on 2024-06-18 05:49:02.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is not making a profit/loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating inefficient.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

1.1. Profitability of Immuneering Corp.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Immuneering earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Immuneering to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Immuneering Corp:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM0.8%-0.8%
TTM0.8%YOY-696,772.0%+696,772.7%
TTM0.8%5Y-165,089.7%+165,090.4%
5Y-165,089.7%10Y-165,089.7%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--168.0%+168.0%
TTM0.8%-209.9%+210.7%
YOY-696,772.0%-242.3%-696,529.7%
5Y-165,089.7%-401.7%-164,688.0%
10Y-165,089.7%-532.2%-164,557.5%
1.1.2. Return on Assets

Shows how efficient Immuneering is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Immuneering to the Biotechnology industry mean.
  • -16.3% Return on Assets means that Immuneering generated $-0.16 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Immuneering Corp:

  • The MRQ is -16.3%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -12.9%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-16.3%TTM-12.9%-3.3%
TTM-12.9%YOY239.6%-252.5%
TTM-12.9%5Y49.2%-62.2%
5Y49.2%10Y49.2%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-16.3%-11.9%-4.4%
TTM-12.9%-11.9%-1.0%
YOY239.6%-11.3%+250.9%
5Y49.2%-13.5%+62.7%
10Y49.2%-14.9%+64.1%
1.1.3. Return on Equity

Shows how efficient Immuneering is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Immuneering to the Biotechnology industry mean.
  • -18.2% Return on Equity means Immuneering generated $-0.18 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Immuneering Corp:

  • The MRQ is -18.2%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -14.4%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-18.2%TTM-14.4%-3.8%
TTM-14.4%YOY263.9%-278.3%
TTM-14.4%5Y56.2%-70.6%
5Y56.2%10Y56.2%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-18.2%-14.2%-4.0%
TTM-14.4%-15.7%+1.3%
YOY263.9%-14.3%+278.2%
5Y56.2%-19.2%+75.4%
10Y56.2%-19.7%+75.9%
3rd party ad coffee SUPPORTERis ad-free.

1.2. Operating Efficiency of Immuneering Corp.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Immuneering is operating .

  • Measures how much profit Immuneering makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Immuneering to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Immuneering Corp:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM0.7%-0.7%
TTM0.7%YOY-778,395.9%+778,396.7%
TTM0.7%5Y-184,309.4%+184,310.2%
5Y-184,309.4%10Y-184,309.4%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--354.6%+354.6%
TTM0.7%-225.9%+226.6%
YOY-778,395.9%-252.2%-778,143.7%
5Y-184,309.4%-428.3%-183,881.1%
10Y-184,309.4%-531.1%-183,778.3%
1.2.2. Operating Ratio

Measures how efficient Immuneering is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Immuneering Corp:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.007+0.007
TTM-0.007YOY94,387.713-94,387.720
TTM-0.0075Y22,220.965-22,220.972
5Y22,220.96510Y22,220.9650.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.004-3.004
TTM-0.0073.332-3.339
YOY94,387.7133.502+94,384.211
5Y22,220.9655.271+22,215.694
10Y22,220.9656.915+22,214.050
3rd party ad coffee SUPPORTERis ad-free.

1.3. Liquidity of Immuneering Corp.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Immuneering is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 14.38 means the company has $14.38 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Immuneering Corp:

  • The MRQ is 14.379. The company is very able to pay all its short-term debts. +2
  • The TTM is 15.994. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ14.379TTM15.994-1.615
TTM15.994YOY20.271-4.277
TTM15.9945Y16.366-0.372
5Y16.36610Y16.3660.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ14.3793.767+10.612
TTM15.9944.000+11.994
YOY20.2714.905+15.366
5Y16.3665.883+10.483
10Y16.3666.286+10.080
1.3.2. Quick Ratio

Measures if Immuneering is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Immuneering to the Biotechnology industry mean.
  • A Quick Ratio of 14.73 means the company can pay off $14.73 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Immuneering Corp:

  • The MRQ is 14.731. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 18.105. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ14.731TTM18.105-3.374
TTM18.105YOY25.602-7.497
TTM18.1055Y20.251-2.145
5Y20.25110Y20.2510.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ14.7313.054+11.677
TTM18.1053.506+14.599
YOY25.6024.756+20.846
5Y20.2515.757+14.494
10Y20.2516.338+13.913
3rd party ad coffee SUPPORTERis ad-free.

1.4. Solvency of Immuneering Corp.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Immuneering assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Immuneering to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.11 means that Immuneering assets are financed with 10.5% credit (debt) and the remaining percentage (100% - 10.5%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Immuneering Corp:

  • The MRQ is 0.105. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.097. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.105TTM0.097+0.008
TTM0.097YOY0.086+0.011
TTM0.0975Y0.249-0.152
5Y0.24910Y0.2490.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1050.330-0.225
TTM0.0970.342-0.245
YOY0.0860.287-0.201
5Y0.2490.368-0.119
10Y0.2490.382-0.133
1.4.2. Debt to Equity Ratio

Measures if Immuneering is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Immuneering to the Biotechnology industry mean.
  • A Debt to Equity ratio of 11.8% means that company has $0.12 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Immuneering Corp:

  • The MRQ is 0.118. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.108. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.118TTM0.108+0.010
TTM0.108YOY0.094+0.014
TTM0.1085Y0.064+0.044
5Y0.06410Y0.0640.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1180.365-0.247
TTM0.1080.415-0.307
YOY0.0940.370-0.276
5Y0.0640.443-0.379
10Y0.0640.476-0.412
3rd party ad coffee SUPPORTERis ad-free.

2. Market Valuation of Immuneering Corp

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Immuneering generates.

  • Above 15 is considered overpriced but always compare Immuneering to the Biotechnology industry mean.
  • A PE ratio of -1.50 means the investor is paying $-1.50 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Immuneering Corp:

  • The EOD is -0.585. Based on the earnings, the company is expensive. -2
  • The MRQ is -1.497. Based on the earnings, the company is expensive. -2
  • The TTM is -3.949. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.585MRQ-1.497+0.912
MRQ-1.497TTM-3.949+2.452
TTM-3.949YOY-4.938+0.988
TTM-3.9495Y-4.320+0.371
5Y-4.32010Y-4.3200.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.585-2.341+1.756
MRQ-1.497-2.997+1.500
TTM-3.949-2.882-1.067
YOY-4.938-3.553-1.385
5Y-4.320-6.262+1.942
10Y-4.320-6.288+1.968
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Immuneering Corp:

  • The EOD is -0.539. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -1.380. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -4.398. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.539MRQ-1.380+0.840
MRQ-1.380TTM-4.398+3.018
TTM-4.398YOY-5.459+1.061
TTM-4.3985Y-4.589+0.191
5Y-4.58910Y-4.5890.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.539-2.932+2.393
MRQ-1.380-3.739+2.359
TTM-4.398-3.776-0.622
YOY-5.459-4.917-0.542
5Y-4.589-7.942+3.353
10Y-4.589-8.503+3.914
3rd party ad coffee SUPPORTERis ad-free.
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Immuneering is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 1.09 means the investor is paying $1.09 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Immuneering Corp:

  • The EOD is 0.426. Based on the equity, the company is cheap. +2
  • The MRQ is 1.089. Based on the equity, the company is underpriced. +1
  • The TTM is 2.074. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD0.426MRQ1.089-0.663
MRQ1.089TTM2.074-0.986
TTM2.074YOY2.235-0.160
TTM2.0745Y1.566+0.509
5Y1.56610Y1.5660.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD0.4261.843-1.417
MRQ1.0892.249-1.160
TTM2.0742.301-0.227
YOY2.2352.412-0.177
5Y1.5663.782-2.216
10Y1.5664.212-2.646
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Immuneering Corp.

3.1. Institutions holding Immuneering Corp

Institutions are holding 34.878% of the shares of Immuneering Corp.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-03-31Cormorant Asset Management, LLC11.11260.41783295273-909091-21.6226
2024-03-31BlackRock Inc4.64410.00011377120-720286-34.3418
2024-03-31Vanguard Group Inc4.05910.0001120366612985112.0925
2024-03-31T. Rowe Price Associates, Inc.3.06970.0003910266-2467834-73.0539
2024-03-31Geode Capital Management, LLC1.55980.0001462520182874.1165
2024-03-31Goldman Sachs Group Inc1.53180.0002454233-459885-50.3092
2024-03-31State Street Corporation1.2710.000137689632340.8655
2024-03-31HighVista Strategies LLC0.85830.262325451300
2024-03-31FMR Inc0.78640.0001233198-256249-52.3548
2024-03-31Northern Trust Corp0.59350.0001176005-7922-4.3071
2024-03-31TD Asset Management Inc0.50880.0004150876-47000-23.7522
2024-03-31Bridgeway Capital Management, LLC0.38460.006711404975000192.0664
2024-03-31Exchange Traded Concepts, LLC0.33130.00739825480838464.1594
2024-03-31SOUTHPORT MANAGEMENT, L.L.C.0.30380.95829010065000258.9641
2024-03-31Manufacturers Life Insurance Co0.29450.000287324-3858-4.2311
2024-03-31Millennium Management LLC0.21330.00016326251824453.0862
2024-03-31Charles Schwab Investment Management Inc0.204106051200
2024-03-31Bank of New York Mellon Corp0.1814053778-10251-16.0099
2024-03-31Adage Capital Partners Gp LLC0.16860.000350000-50000-50
2024-03-31Morgan Stanley - Brokerage Accounts0.1538045619-10529-18.7522
Total 32.23051.65449557464-4518871-47.3%

3.2. Funds holding Immuneering Corp

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-04-30Vanguard Total Stock Mkt Idx Inv2.48260.000173618800
2024-03-31T. Rowe Price Health Sciences2.03690.0113604020-518599-46.1955
2024-05-30iShares Russell 2000 ETF1.62650.001148232236520.7629
2024-04-30Vanguard Institutional Extnd Mkt Idx Tr0.97530.000428919600
2024-03-31Fidelity Small Cap Index0.74580.002422116033041.5166
2024-05-30iShares Russell 2000 Growth ETF0.48850.001814486900
2024-04-30Fidelity Extended Market Index0.38590.0004114442-1037-0.898
2024-05-31State St Russell Sm/Mid Cp® Indx NL Cl C0.38380.000411380000
2024-03-31Bridgeway Ultra-Small Company Market0.37080.164910994975000214.5984
2023-12-31TD Health Sciences - I0.33360.05819893800
2024-04-30Vanguard Russell 2000 ETF0.28350.0013840652880.3438
2024-05-31Range Oncology Therapeutics ETF0.26760.66737935400
2024-05-31State St Russell Sm Cap® Indx SL Cl I0.25190.00117470000
2024-03-31NT R2000 Index Fund - NL0.20590.002461053-3552-5.498
2023-12-31NT R2000 Growth Index Fund - NL0.17860.01055297200
2024-04-30Schwab Small Cap Index0.17480.00135183500
2024-03-31NT R2000 Index Fund - DC - NL - 20.16350.002448484-2393-4.7035
2023-09-30BlackRock Extended Mkt Composite0.1620.0026480394170.8756
2024-05-30iShares Micro-Cap ETF0.15770.007746750-650-1.3713
2024-05-30iShares Russell 2000 Value ETF0.14590.000543259-58-0.1339
Total 11.82110.9383505395-443628-12.7%

3.3. Insider Transactions

Insiders are holding 29.152% of the shares of Immuneering Corp.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-04-01Cormorant Asset Management, LpSELL4000002.9
2024-03-22Harold Eugene BrakewoodBUY39002.57
2024-03-22Peter FeinbergBUY250002.55
2024-03-21Mallory MoralesBUY11072.72
2024-03-20Leah R NeufeldBUY38182.88
2024-03-19Benjamin J ZeskindBUY200002.77
2024-03-18Ann E BermanBUY579652.13
2024-03-14Cormorant Asset Management, LpSELL5090913.72
3rd party ad coffee SUPPORTERis ad-free.

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Immuneering Corp compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.400-0.161-60%-0.390-2%0.156-356%0.156-356%
Book Value Per Share--2.6553.275-19%3.905-32%2.543+4%2.543+4%
Current Ratio--14.37915.994-10%20.271-29%16.366-12%16.366-12%
Debt To Asset Ratio--0.1050.097+9%0.086+23%0.249-58%0.249-58%
Debt To Equity Ratio--0.1180.108+9%0.094+25%0.064+85%0.064+85%
Dividend Per Share----0%-0%-0%-0%
Eps---0.483-0.457-5%-0.432-11%-0.335-31%-0.335-31%
Free Cash Flow Per Share---0.524-0.425-19%-0.395-25%-0.308-41%-0.308-41%
Free Cash Flow To Equity Per Share---0.491-0.179-64%-0.395-20%0.265-285%0.265-285%
Gross Profit Margin--0.9920.998-1%1.000-1%1.000-1%1.000-1%
Intrinsic Value_10Y_max---30.771--------
Intrinsic Value_10Y_min---26.089--------
Intrinsic Value_1Y_max---1.741--------
Intrinsic Value_1Y_min---1.710--------
Intrinsic Value_3Y_max---6.255--------
Intrinsic Value_3Y_min---5.951--------
Intrinsic Value_5Y_max---12.001--------
Intrinsic Value_5Y_min---11.051--------
Market Cap33508342.000-156%85698326.000208018601.000-59%254203771.500-66%194561190.353-56%194561190.353-56%
Net Profit Margin---0.008-100%-6967.7200%-1650.8970%-1650.8970%
Operating Margin---0.007-100%-7783.9590%-1843.0940%-1843.0940%
Operating Ratio----0.0070%94387.713-100%22220.965-100%22220.965-100%
Pb Ratio0.426-156%1.0892.074-48%2.235-51%1.566-30%1.566-30%
Pe Ratio-0.585+61%-1.497-3.949+164%-4.938+230%-4.320+189%-4.320+189%
Price Per Share1.130-156%2.8907.015-59%8.573-66%6.561-56%6.561-56%
Price To Free Cash Flow Ratio-0.539+61%-1.380-4.398+219%-5.459+296%-4.589+233%-4.589+233%
Price To Total Gains Ratio-2.827+61%-7.230-6.655-8%-21.860+202%-30.304+319%-30.304+319%
Quick Ratio--14.73118.105-19%25.602-42%20.251-27%20.251-27%
Return On Assets---0.163-0.129-20%2.396-107%0.492-133%0.492-133%
Return On Equity---0.182-0.144-21%2.639-107%0.562-132%0.562-132%
Total Gains Per Share---0.400-0.161-60%-0.390-2%0.156-356%0.156-356%
Usd Book Value--78722729.00097105241.000-19%115781981.750-32%75399204.647+4%75399204.647+4%
Usd Book Value Change Per Share---0.400-0.161-60%-0.390-2%0.156-356%0.156-356%
Usd Book Value Per Share--2.6553.275-19%3.905-32%2.543+4%2.543+4%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.483-0.457-5%-0.432-11%-0.335-31%-0.335-31%
Usd Free Cash Flow---15528592.000-12598490.250-19%-11723417.500-25%-9133507.529-41%-9133507.529-41%
Usd Free Cash Flow Per Share---0.524-0.425-19%-0.395-25%-0.308-41%-0.308-41%
Usd Free Cash Flow To Equity Per Share---0.491-0.179-64%-0.395-20%0.265-285%0.265-285%
Usd Market Cap33508342.000-156%85698326.000208018601.000-59%254203771.500-66%194561190.353-56%194561190.353-56%
Usd Price Per Share1.130-156%2.8907.015-59%8.573-66%6.561-56%6.561-56%
Usd Profit---14307829.000-13543820.000-5%256346147.750-106%53398034.059-127%53398034.059-127%
Usd Revenue----0%33313.750-100%276967.588-100%276967.588-100%
Usd Total Gains Per Share---0.400-0.161-60%-0.390-2%0.156-356%0.156-356%
 EOD+3 -5MRQTTM+2 -30YOY+4 -285Y+8 -2410Y+8 -24

4.2. Fundamental Score

Let's check the fundamental score of Immuneering Corp based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.585
Price to Book Ratio (EOD)Between0-10.426
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than114.731
Current Ratio (MRQ)Greater than114.379
Debt to Asset Ratio (MRQ)Less than10.105
Debt to Equity Ratio (MRQ)Less than10.118
Return on Equity (MRQ)Greater than0.15-0.182
Return on Assets (MRQ)Greater than0.05-0.163
Total5/10 (50.0%)

4.3. Technical Score

Let's check the technical score of Immuneering Corp based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5035.254
Ma 20Greater thanMa 501.417
Ma 50Greater thanMa 1001.467
Ma 100Greater thanMa 2002.816
OpenGreater thanClose1.100
Total0/5 (0.0%)



Latest Balance Sheet

Balance Sheet of 2024-03-31. Currency in USD. All numbers in thousands.

Summary
Total Assets87,983
Total Liabilities9,260
Total Stockholder Equity78,723
 As reported
Total Liabilities 9,260
Total Stockholder Equity+ 78,723
Total Assets = 87,983

Assets

Total Assets87,983
Total Current Assets74,447
Long-term Assets13,535
Total Current Assets
Cash And Cash Equivalents 66,287
Short-term Investments 4,991
Other Current Assets 3,169
Total Current Assets  (as reported)74,447
Total Current Assets  (calculated)74,447
+/-0
Long-term Assets
Property Plant Equipment 5,253
Goodwill 6,690
Intangible Assets 372
Long-term Assets Other 1,219
Long-term Assets  (as reported)13,535
Long-term Assets  (calculated)13,535
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities5,177
Long-term Liabilities4,083
Total Stockholder Equity78,723
Total Current Liabilities
Short-term Debt 299
Accounts payable 2,271
Other Current Liabilities 2,608
Total Current Liabilities  (as reported)5,177
Total Current Liabilities  (calculated)5,177
+/-0
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt4,083
Long-term Liabilities  (as reported)4,083
Long-term Liabilities  (calculated)4,083
+/-0
Total Stockholder Equity
Common Stock30
Retained Earnings -177,566
Accumulated Other Comprehensive Income -1
Other Stockholders Equity 256,261
Total Stockholder Equity (as reported)78,723
Total Stockholder Equity (calculated)78,723
+/-0
Other
Capital Stock30
Cash and Short Term Investments 71,278
Common Stock Shares Outstanding 29,370
Liabilities and Stockholders Equity 87,983
Net Debt -61,906
Net Invested Capital 78,723
Net Working Capital 69,270
Property Plant and Equipment Gross 6,072
Short Long Term Debt Total 4,381



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-31
> Total Assets 
0
0
0
38,423
32,857
53,042
164,042
166,705
152,447
142,050
133,692
122,367
107,696
124,895
113,881
102,585
87,983
87,983102,585113,881124,895107,696122,367133,692142,050152,447166,705164,04253,04232,85738,423000
   > Total Current Assets 
0
0
0
37,731
32,183
51,437
153,311
152,334
139,530
129,170
120,025
108,747
94,234
111,507
100,583
89,084
74,447
74,44789,084100,583111,50794,234108,747120,025129,170139,530152,334153,31151,43732,18337,731000
       Cash And Cash Equivalents 
0
0
0
37,090
30,934
50,245
106,928
74,888
75,205
87,937
76,418
72,637
77,430
104,017
68,040
59,406
66,287
66,28759,40668,040104,01777,43072,63776,41887,93775,20574,888106,92850,24530,93437,090000
       Short-term Investments 
0
0
0
0
0
0
42,550
74,311
62,566
40,164
40,779
32,888
14,106
4,968
29,202
26,260
4,991
4,99126,26029,2024,96814,10632,88840,77940,16462,56674,31142,550000000
       Net Receivables 
0
0
0
500
492
495
471
246
280
178
70
12
1
744
0
0
0
00074411270178280246471495492500000
       Other Current Assets 
0
0
0
141
757
697
3,361
2,889
1,480
890
2,757
3,210
2,697
2,522
3,340
3,418
3,169
3,1693,4183,3402,5222,6973,2102,7578901,4802,8893,361697757141000
   > Long-term Assets 
0
0
0
692
674
1,605
10,732
14,371
12,917
12,880
13,667
13,620
13,463
13,388
13,298
13,501
13,535
13,53513,50113,29813,38813,46313,62013,66712,88012,91714,37110,7321,605674692000
       Property Plant Equipment 
0
0
0
677
660
645
619
6,131
5,706
5,676
5,823
5,777
5,627
5,560
5,477
5,396
5,253
5,2535,3965,4775,5605,6275,7775,8235,6765,7066,131619645660677000
       Goodwill 
0
0
0
0
0
0
0
6,702
6,690
6,690
6,690
6,690
6,690
6,690
6,690
6,690
6,690
6,6906,6906,6906,6906,6906,6906,6906,6906,6906,7020000000
       Long Term Investments 
0
0
0
0
0
0
10,099
997
0
0
0
0
0
0
0
0
0
00000000099710,099000000
       Intangible Assets 
0
0
0
0
0
0
0
439
431
424
416
409
402
394
387
380
372
3723803873944024094164244314390000000
       Other Assets 
0
0
0
0
14
960
14
102
90
90
737
744
0
744
0
0
0
0007440744737909010214960140000
> Total Liabilities 
0
0
0
60,904
3,282
88,228
5,749
10,725
8,391
8,455
11,798
12,517
9,907
9,791
9,863
12,008
9,260
9,26012,0089,8639,7919,90712,51711,7988,4558,39110,7255,74988,2283,28260,904000
   > Total Current Liabilities 
0
0
0
2,256
2,758
4,832
5,267
5,634
3,674
3,801
7,256
8,054
5,526
5,479
5,622
7,846
5,177
5,1777,8465,6225,4795,5268,0547,2563,8013,6745,6345,2674,8322,7582,256000
       Short-term Debt 
0
0
0
76
78
81
83
274
265
286
309
379
363
333
302
300
299
29930030233336337930928626527483817876000
       Accounts payable 
0
0
0
1,481
1,369
1,433
1,795
1,394
1,642
1,240
2,338
3,155
2,724
2,693
1,941
2,112
2,271
2,2712,1121,9412,6932,7243,1552,3381,2401,6421,3941,7951,4331,3691,481000
       Other Current Liabilities 
0
0
0
699
1,311
3,319
3,389
3,965
1,766
2,274
4,609
4,521
2,439
26
3,380
260
2,608
2,6082603,380262,4394,5214,6092,2741,7663,9653,3893,3191,311699000
   > Long-term Liabilities 
0
0
0
58,649
524
83,396
482
5,091
4,717
4,655
4,543
4,463
4,381
4,312
4,241
4,163
4,083
4,0834,1634,2414,3124,3814,4634,5434,6554,7175,09148283,39652458,649000
       Warrants
0
0
0
0
0
165,785
0
0
0
0
0
0
0
0
0
0
0
00000000000165,78500000
       Other Liabilities 
0
0
0
0
0
0
0
0
10
10
0
0
0
0
0
0
0
0000000101000000000
> Total Stockholder Equity
0
0
0
-22,481
29,575
-35,186
158,294
155,980
144,056
133,595
121,893
109,850
97,790
115,104
104,018
90,576
78,723
78,72390,576104,018115,10497,790109,850121,893133,595144,056155,980158,294-35,18629,575-22,481000
   Common Stock
0
0
0
5
14
5
26
26
26
26
26
26
26
29
29
29
30
30292929262626262626265145000
   Retained Earnings Total Equity000-135,580-123,391-109,787-96,541-83,697-72,170-59,273-48,489-39,95500000
   Accumulated Other Comprehensive Income 
0
0
0
0
0
-149,424,598
-5
-49
-167
-182
-142
-30
1
-2
6
-1
-1
-1-16-21-30-142-182-167-49-5-149,424,59800000
   Capital Surplus 
0
0
0
0
0
4,764
206,761
215,276
216,367
217,447
218,551
219,641
221,154
250,657
0
0
0
000250,657221,154219,641218,551217,447216,367215,276206,7614,76400000
   Treasury Stock00000000000000000
   Other Stockholders Equity 
0
0
0
3,251
61,529
87,656,601
-163,835,630
215,276
216,367
217,447
218,551
219,641
221,154
250,657
252,158
253,806
256,261
256,261253,806252,158250,657221,154219,641218,551217,447216,367215,276-163,835,63087,656,60161,5293,251000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue0
Cost of Revenue-764
Gross Profit-764-764
 
Operating Income (+$)
Gross Profit-764
Operating Expense-57,649
Operating Income-58,413-58,413
 
Operating Expense (+$)
Research Development41,401
Selling General Administrative16,760
Selling And Marketing Expenses-16,743,354
Operating Expense57,649-16,685,194
 
Net Interest Income (+$)
Interest Income3,369
Interest Expense-0
Other Finance Cost-0
Net Interest Income3,369
 
Pretax Income (+$)
Operating Income-58,413
Net Interest Income3,369
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-53,472-63,354
EBIT - interestExpense = -58,413
-53,472
-53,472
Interest Expense0
Earnings Before Interest and Taxes (EBIT)-58,413-53,472
Earnings Before Interest and Taxes (EBITDA)-57,649
 
After tax Income (+$)
Income Before Tax-53,472
Tax Provision-0
Net Income From Continuing Ops-51,634-53,472
Net Income-53,472
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses58,413
Total Other Income/Expenses Net4,941-3,369
 

Technical Analysis of Immuneering
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Immuneering. The general trend of Immuneering is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Immuneering's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Immuneering Corp.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 1.3 < 1.7783 < 1.9.

The bearish price targets are: .

Tweet this
Immuneering Corp Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Immuneering Corp. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Immuneering Corp Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Immuneering Corp. The current macd is -0.10263633.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Immuneering price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Immuneering. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Immuneering price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Immuneering Corp Daily Moving Average Convergence/Divergence (MACD) ChartImmuneering Corp Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Immuneering Corp. The current adx is 23.64.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Immuneering shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
Immuneering Corp Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Immuneering Corp. The current sar is 1.69449528.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Immuneering Corp Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Immuneering Corp. The current rsi is 35.25. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
Immuneering Corp Daily Relative Strength Index (RSI) ChartImmuneering Corp Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Immuneering Corp. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Immuneering price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Immuneering Corp Daily Stochastic Oscillator ChartImmuneering Corp Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Immuneering Corp. The current cci is -173.778662.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Immuneering Corp Daily Commodity Channel Index (CCI) ChartImmuneering Corp Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Immuneering Corp. The current cmo is -36.40257026.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Immuneering Corp Daily Chande Momentum Oscillator (CMO) ChartImmuneering Corp Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Immuneering Corp. The current willr is -88.23529412.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Immuneering Corp Daily Williams %R ChartImmuneering Corp Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Immuneering Corp.

Immuneering Corp Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Immuneering Corp. The current atr is 0.14632321.

Immuneering Corp Daily Average True Range (ATR) ChartImmuneering Corp Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Immuneering Corp. The current obv is -2,480,520.

Immuneering Corp Daily On-Balance Volume (OBV) ChartImmuneering Corp Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Immuneering Corp. The current mfi is 21.24.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Immuneering Corp Daily Money Flow Index (MFI) ChartImmuneering Corp Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Immuneering Corp.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-02-13DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-15CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-28CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-29DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-01MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-03-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-06STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-07MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-03-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-13STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-14DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-15ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-28RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-01WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-04MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-05STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-11STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-19STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-22WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-26STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-29MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-30STOCH LONG EXITThe %K line crosses below the %D line.
2024-05-01SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-05-02RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-05-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-05-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-05-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-05-10SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-05-13STOCH SHORT EXITThe %K line crosses above the %D line.
2024-05-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-05-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-05-23STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-05-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-05-30STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-06-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-06-07STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-06-10SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-06-11DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-06-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-06-13STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-06-14STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-06-18CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-06-20SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-06-24STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-06-25STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-06-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-06-28MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-07-01DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-07-02STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-07-03MFI LONG ENTRY SHORT CLOSE20 crossover to upside

6.3. Candlestick Patterns

Immuneering Corp Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Immuneering Corp based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5035.254
Ma 20Greater thanMa 501.417
Ma 50Greater thanMa 1001.467
Ma 100Greater thanMa 2002.816
OpenGreater thanClose1.100
Total0/5 (0.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Immuneering with someone you think should read this too:
  • Are you bullish or bearish on Immuneering? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Immuneering? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Immuneering Corp

I send you an email if I find something interesting about Immuneering Corp.


Stay informed about Immuneering Corp.

Receive notifications about Immuneering Corp in your mailbox!